Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 178

1.

Stability of Values for the Activities of Critical Enzymes Assayed in Serum Frozen for Prolonged Time Periods.

Chua C, Tifigiu E, Boroujeni AM, Lin B, Laskar D, Shafique K, Zuretti A, Michl J, Pincus MR.

Ann Clin Lab Sci. 2018 Sep;48(5):618-626.

PMID:
30373867
2.

Low Energy Conformations for S100 Binding Peptide from the Negative Regulatory Domain of p53.

Carty RP, Lin B, Fridman D, Pincus MR.

Protein J. 2018 Dec;37(6):510-517. doi: 10.1007/s10930-018-9799-1.

PMID:
30334121
3.

Major Discrepancies of HCV Viral Loads Determined by Real Time Polymerase Chain Reaction Caused by Use of Collection Tubes that Differ Only with the Presence or Absence of Serum Separator.

Wang X, Momeni A, Eid I, Li L, Brackett F, Davis-Smith B, Wieczorek R, Pincus MR.

Ann Clin Lab Sci. 2018 May;48(3):286-295.

PMID:
29970430
4.

Mitochondrial Iron Accumulation in Parietal and Chief Cells in Iron Pill Gastritis Following Billroth II Gastrectomy: Case Report Including Electron Microscopic Examination.

Shafique K, Araujo JL, Veluvolu R, Cassai N, Desoto-Lapaix F, Pincus MR, Wieczorek RL.

Ann Clin Lab Sci. 2017 May;47(3):354-356.

PMID:
28667040
5.

Emerging Role of MDM2 as Target for Anti-Cancer Therapy: A Review.

Shaikh MF, Morano WF, Lee J, Gleeson E, Babcock BD, Michl J, Sarafraz-Yazdi E, Pincus MR, Bowne WB.

Ann Clin Lab Sci. 2016 Dec;46(6):627-634. Review.

PMID:
27993876
6.

Narcotic Analgesics and Common Drugs of Abuse: Clinical Correlations and Laboratory Assessment.

Bluth MH, Pincus MR.

Clin Lab Med. 2016 Dec;36(4):603-634. doi: 10.1016/j.cll.2016.07.013. Review.

PMID:
27842782
7.

Metastatic Small Cell Carcinoma of the Lung: An Unusual Cause of Acute Fulminant Hepatic Failure.

Maglantay R, Qin J, Lanjewar S, Wieczorek R, Saad H, Cochran E, Harper A, Al-Ajam M, Goozner B, Blumenthal D, Pincus MR.

Fed Pract. 2016 Aug;33(Suppl 5):30S-34S.

8.

Papillary urothelial carcinoma with squamous differentiation in association with human papilloma virus: case report and literature review.

Guma S, Maglantay R, Lau R, Wieczorek R, Melamed J, Deng FM, Zhou M, Makarov D, Lee P, Pincus MR, Pei ZH.

Am J Clin Exp Urol. 2016 Jan 28;4(1):12-6. eCollection 2016.

9.

Ex vivo Efficacy of Anti-Cancer Drug PNC-27 in the Treatment of Patient-Derived Epithelial Ovarian Cancer.

Sarafraz-Yazdi E, Gorelick C, Wagreich AR, Salame G, Angert M, Gartman CH, Gupta V, Bowne WB, Lee YC, Abulafia O, Pincus MR, Michl J.

Ann Clin Lab Sci. 2015 Fall;45(6):650-8.

PMID:
26663795
10.

Reproducibility of Serum Potassium Values in Serum From Blood Samples Stored for Increasing Times Prior to Centrifugation and Analysis.

Harper A, Lu C, Sun Y, Garcia R, Rets A, Alexis H, Saad H, Eid I, Harris L, Marshall B, Tafani E, Pincus MR.

J Clin Lab Anal. 2016 May;30(3):244-7. doi: 10.1002/jcla.21843. Epub 2015 Apr 13.

11.

De novo large cell neuroendocrine carcinoma of the prostate, case report and literature review.

Acosta-Gonzalez G, Qin J, Wieczorek R, Melamed J, Deng FM, Zhou M, Makarov D, Ye F, Pei Z, Pincus MR, Lee P.

Am J Clin Exp Urol. 2014 Dec 25;2(4):337-42. eCollection 2014.

12.

Beyond infectious disease: welcome to the era of population microbiology.

Pincus MR, Pei Z.

Clin Lab Med. 2014 Dec;34(4):xi-xiii. doi: 10.1016/j.cll.2014.09.001. Epub 2014 Oct 31. No abstract available.

PMID:
25439278
13.

The low-energy conformations of gonadotropin-releasing hormone in aqueous solution.

Pincus MR, Woo J, Monaco R, Lubowsky J, Avitable MJ, Carty RP.

Protein J. 2014 Dec;33(6):565-74. doi: 10.1007/s10930-014-9589-3.

PMID:
25404067
14.

Low energy conformations for gonadotropin-releasing hormone with D- and L-amino acid substitutions for Gly 6: possible receptor-bound conformations.

Pincus MR, Woo J, Monaco R, Lubowsky J, Carty RP.

Protein J. 2014 Dec;33(6):575-87. doi: 10.1007/s10930-014-9590-x.

PMID:
25399235
15.

The anti-cancer peptide, PNC-27, induces tumor cell necrosis of a poorly differentiated non-solid tissue human leukemia cell line that depends on expression of HDM-2 in the plasma membrane of these cells.

Davitt K, Babcock BD, Fenelus M, Poon CK, Sarkar A, Trivigno V, Zolkind PA, Matthew SM, Grin'kina N, Orynbayeva Z, Shaikh MF, Adler V, Michl J, Sarafraz-Yazdi E, Pincus MR, Bowne WB.

Ann Clin Lab Sci. 2014 Summer;44(3):241-8.

PMID:
25117093
16.

Imbalanced expression of Tif1γ inhibits pancreatic ductal epithelial cell growth.

Ligr M, Wu X, Daniels G, Zhang D, Wang H, Hajdu C, Wang J, Pan R, Pei Z, Zhang L, Melis M, Pincus MR, Saunders JK, Lee P, Xu R.

Am J Cancer Res. 2014 May 26;4(3):196-210. eCollection 2014.

17.

Stability of BUN and creatinine determinations on the Siemens Advia 1800 analyzer.

Qin J, Wang H, Rets A, Harari S, Alexis H, Eid I, Pincus MR.

J Clin Lab Anal. 2013 Nov;27(6):435-7. doi: 10.1002/jcla.21624.

18.

Tumor-targeting peptides and small molecules as anti-cancer agents to overcome drug resistance.

Sarafraz-Yazdi E, Pincus MR, Michl J.

Curr Med Chem. 2014;21(14):1618-30. Review.

PMID:
23992333
19.

Comparison of glucose determinations on blood samples collected in three types of tubes.

Li G, Cabanero M, Wang Z, Wang H, Huang T, Alexis H, Eid I, Muth G, Pincus MR.

Ann Clin Lab Sci. 2013 Summer;43(3):278-84.

PMID:
23884222
21.

Parotid gland abscess caused by Haemophilus paraphrophilus: a case report.

Rets AV, Eid I, Lutwick L, Pincus MR.

Ann Clin Lab Sci. 2012 Fall;42(4):422-3.

PMID:
23090740
22.

Stability of electrolyte determinations on the Siemens Advia 1800 analyzer.

Garcia R, Li G, Wang Z, Cabanero M, Pincus MR.

J Clin Lab Anal. 2012 Sep;26(5):372-5. doi: 10.1002/jcla.21533.

23.

Anti-cancer peptides from ras-p21 and p53 proteins.

Pincus MR, Fenelus M, Sarafraz-Yazdi E, Adler V, Bowne W, Michl J.

Curr Pharm Des. 2011;17(25):2677-98. Review.

PMID:
21728981
24.

The anti-cancer peptide, PNC-27, induces tumor cell lysis as the intact peptide.

Sookraj KA, Bowne WB, Adler V, Sarafraz-Yazdi E, Michl J, Pincus MR.

Cancer Chemother Pharmacol. 2010 Jul;66(2):325-31. doi: 10.1007/s00280-009-1166-7. Epub 2010 Feb 25.

PMID:
20182728
25.

Anticancer peptide PNC-27 adopts an HDM-2-binding conformation and kills cancer cells by binding to HDM-2 in their membranes.

Sarafraz-Yazdi E, Bowne WB, Adler V, Sookraj KA, Wu V, Shteyler V, Patel H, Oxbury W, Brandt-Rauf P, Zenilman ME, Michl J, Pincus MR.

Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):1918-23. doi: 10.1073/pnas.0909364107. Epub 2010 Jan 11.

26.

Utility of desmin and a Masson's trichrome method to detect early acute myocardial infarction in autopsy tissues.

Ouyang J, Guzman M, Desoto-Lapaix F, Pincus MR, Wieczorek R.

Int J Clin Exp Pathol. 2009 Sep 20;3(1):98-105.

27.

A peptide from a ras effector-domain blocks ras-dependent cardiac hypertrophy in myocytes.

Deng L, Boujdir M, Tremontano A, Pincus MR, El-Sherif N.

Ann Clin Lab Sci. 2009 Fall;39(4):351-60.

PMID:
19880762
28.

Conformational effects of a common codon 751 polymorphism on the C-terminal domain of the xeroderma pigmentosum D protein.

Monaco R, Rosal R, Dolan MA, Pincus MR, Freyer G, Brandt-Rauf PW.

J Carcinog. 2009;8:12. doi: 10.4103/1477-3163.54918.

29.

Case report: Paenibacillus thiaminolyticus: a new cause of human infection, inducing bacteremia in a patient on hemodialysis.

Ouyang J, Pei Z, Lutwick L, Dalal S, Yang L, Cassai N, Sandhu K, Hanna B, Wieczorek RL, Bluth M, Pincus MR.

Ann Clin Lab Sci. 2008 Autumn;38(4):393-400.

30.

The penetratin sequence in the anticancer PNC-28 peptide causes tumor cell necrosis rather than apoptosis of human pancreatic cancer cells.

Bowne WB, Sookraj KA, Vishnevetsky M, Adler V, Sarafraz-Yazdi E, Lou S, Koenke J, Shteyler V, Ikram K, Harding M, Bluth MH, Ng M, Brandt-Rauf PW, Hannan R, Bradu S, Zenilman ME, Michl J, Pincus MR.

Ann Surg Oncol. 2008 Dec;15(12):3588-600. doi: 10.1245/s10434-008-0147-0. Epub 2008 Oct 18.

PMID:
18931881
31.

Immunoglobulin E antibodies from pancreatic cancer patients mediate antibody-dependent cell-mediated cytotoxicity against pancreatic cancer cells.

Fu SL, Pierre J, Smith-Norowitz TA, Hagler M, Bowne W, Pincus MR, Mueller CM, Zenilman ME, Bluth MH.

Clin Exp Immunol. 2008 Sep;153(3):401-9. doi: 10.1111/j.1365-2249.2008.03726.x.

32.

IgG anti-cardiomyocyte antibodies in giant cell myocarditis.

HooKim K, deRoux S, Igbokwe A, Stanek A, Koo J, Hsu J, Pincus MR, Bluth MH.

Ann Clin Lab Sci. 2008 Winter;38(1):83-7.

PMID:
18316787
33.

Site-specific phosphorylation of raf in cells containing oncogenic ras-p21 is likely mediated by jun-N-terminal kinase.

Adler V, Bowne W, Michl J, Sookraj KA, Ikram K, Pestka S, Izotova L, Zenilman M, Friedman FK, Qu Y, Pincus MR.

Ann Clin Lab Sci. 2008 Winter;38(1):47-56.

PMID:
18316782
34.

Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations.

Cai CQ, Peng Y, Buckley MT, Wei J, Chen F, Liebes L, Gerald WL, Pincus MR, Osman I, Lee P.

Oncogene. 2008 May 15;27(22):3201-10. doi: 10.1038/sj.onc.1210983. Epub 2008 Jan 14.

PMID:
18193092
35.

Two peptides derived from ras-p21 induce either phenotypic reversion or tumor cell necrosis of ras-transformed human cancer cells.

Adler V, Bowne W, Kamran I, Michl J, Friedman FK, Chin E, Zenilman M, Pincus MR.

Cancer Chemother Pharmacol. 2008 Aug;62(3):491-8. Epub 2007 Dec 8.

PMID:
18066549
36.

Novel peptides from the RAS-p21 and p53 proteins for the treatment of cancer.

Bowne WB, Michl J, Bluth MH, Zenilman ME, Pincus MR.

Cancer Ther. 2007;5B:331-344.

37.

Conformational effects of a common codon 399 polymorphism on the BRCT1 domain of the XRCC1 protein.

Monaco R, Rosal R, Dolan MA, Pincus MR, Brandt-Rauf PW.

Protein J. 2007 Dec;26(8):541-6.

PMID:
17899335
38.

The dual-specificity kinases, TOPK and DYRK1A, are critical for oocyte maturation induced by wild-type--but not by oncogenic--ras-p21 protein.

Qu Y, Adler V, Izotova L, Pestka S, Bowne W, Michl J, Boutjdir M, Friedman FK, Pincus MR.

Front Biosci. 2007 Sep 1;12:5089-97.

PMID:
17569632
39.

Novel mutations of epidermal growth factor receptor in localized prostate cancer.

Douglas DA, Zhong H, Ro JY, Oddoux C, Berger AD, Pincus MR, Satagopan JM, Gerald WL, Scher HI, Lee P, Osman I.

Front Biosci. 2006 Sep 1;11:2518-25.

PMID:
16720329
40.

Two dual specificity kinases are preferentially induced by wild-type rather than by oncogenic RAS-P21 in Xenopus oocytes.

Qu Y, Adler V, Chu T, Platica O, Michl J, Pestka S, Izotova L, Boutjdir M, Pincus MR.

Front Biosci. 2006 Sep 1;11:2420-7.

PMID:
16720323
41.

PNC-28, a p53-derived peptide that is cytotoxic to cancer cells, blocks pancreatic cancer cell growth in vivo.

Michl J, Scharf B, Schmidt A, Huynh C, Hannan R, von Gizycki H, Friedman FK, Brandt-Rauf P, Fine RL, Pincus MR.

Int J Cancer. 2006 Oct 1;119(7):1577-85.

44.

Functional interactions of Raf and MEK with Jun-N-terminal kinase (JNK) result in a positive feedback loop on the oncogenic Ras signaling pathway.

Adler V, Qu Y, Smith SJ, Izotova L, Pestka S, Kung HF, Lin M, Friedman FK, Chie L, Chung D, Boutjdir M, Pincus MR.

Biochemistry. 2005 Aug 16;44(32):10784-95.

PMID:
16086581
45.

The role of alpha-helical structure in p53 peptides as a determinant for their mechanism of cell death: necrosis versus apoptosis.

Rosal R, Brandt-Rauf P, Pincus MR, Wang H, Mao Y, Li Y, Fine RL.

Adv Drug Deliv Rev. 2005 Feb 28;57(4):653-60. Epub 2005 Jan 8. Review.

PMID:
15722169
47.

Computational protein chemistry of p53 and p53 peptides.

Brandt-Rauf PW, Rosal RV, Fine RL, Pincus MR.

Front Biosci. 2004 Sep 1;9:2778-87. Review.

PMID:
15353313
48.

An effector peptide from glutathione-S-transferase-pi strongly and selectively blocks mitotic signaling by oncogenic ras-p21.

Chie L, Adler V, Friedman FK, Chung D, Pincus MR.

Protein J. 2004 Apr;23(3):235-8.

PMID:
15200055
50.

Supplemental Content

Loading ...
Support Center